Edgewater Capital Partners is a Cleveland-based private equity firm with a difference. A Deep Sector Expertise in Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals enables accelerated diligence, certainty to close, and real value creation. We espouse a Growth Enabling Philosophy, with thoughtful, but prudent investment in people, infrastructure, and technology to unlock the true potential of our portfolio companies. And Edgewater is not traditional private equity; our attitude is different. We call it Midwestern Values – honesty, integrity, and transparency. We bring an attitude of humility that builds an environment of trust and collaboration. This is particularly important in the lower middle market where we operate. Nearly half of our transactions are owner-operator situations where the owners have built their company from scratch, and cultural fit with an investment partner is fundamental. The result is a full alignment of interests and culture making Edgewater a successful steward of the companies we invest in. Visit us at www.edgewatercapital.com.

For almost 20 years, GL CHEMTEC (“GLC”) has been a leading chemistry-based CRO supporting the pharmaceutical industry and broader Life Sciences sector. GLC specializes in advanced multi-step organic synthesis, process R&D, and scale-up services to support API development, as well as advanced polymer chemistry for drug delivery and devices. GLC has a particular focus on the development of new bio-based materials inspired by the 12 Principles of Green Chemistry. Operating from two modern, North American-based facilities, GLC has the experience and capabilities to deliver materials ranging from milligrams to hundreds of kilos. GLC is the partner of choice from small emerging biotechs to Big Pharma and other Life Science organizations, and is recognized for its speed and client-centric business model. Visit us at www.glchemtec.ca.

Prolytix, formerly Haematologic Technologies, has 30+ years of experience in protein chemistry, which ensures our team will identify and solve the challenges of your large molecule product. Our services in research and development, characterization by high-resolution mass spectrometry (HRMS), GxP testing, and custom collection devices assist clients worldwide. Using an agile, consultative approach, we support your product’s development from discovery through GMP release. With our proven CMC and regulatory expertise from IND through BLA to our accessible, attentive, and seasoned team, Prolytix is the go-to partner for protein therapeutic projects from routine to complex. For advanced protein development, go with the pro — Prolytix. To learn more about our expertise, services, and products, visit GoProlytix.com. Websitehttp://www.goprolytix.com

Board of directors and C-Suite pharmaceutical services business advisory firm providing direct, dedicated senior leadership support, strategic direction and industry expertise to define opportunities, augment M&A transactions, create strategic sales and growth plans, enhance/develop sales teams, install infrastructure and build capabilities. Operate in senior executive, board advisory and interim executive roles to drive revenue growth and maximize enterprise value: business development, global sales team development. Also operate as key partner to Private Equity and Investment Banking community providing M&A and portfolio company support, developing growth narrative, crisis management, and energizing top line growth.

For over 30 years, Particle Dynamics has supplied innovative technologies, quality ingredients and custom processing capabilities that deliver solutions for our customers. Simply said, our technologies make our customers’ products perform better. We provide particle processing, delivery technologies, and dose manufacturing to the pharmaceutical, consumer health, OTC, and nutraceutical markets. Particle Dynamics is organized around six key Technology and Service lines, including Spray Drying, Continuous Granulation, Micro-encapsulation, Iron Deficiency Technologies, Dose Manufacturing and Product/Process Innovation Services. In addition, the company holds leading global positions in Direct Compression products such as Direct Compression Calcium Carbonate and Magnesium Carbonate.

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

SOCMA, the Society of Chemical Manufacturers and Affiliates, Inc., is the only U.S. based trade association dedicated solely to the batch, custom and specialty chemical industry. From its office in Washington, DC, SOCMA advocates for U.S. laws and regulations that affect our members' competitiveness and bottom line.Today, SOCMA member companies encompass every segment of the industry and manufacture tens of thousands products annually that are valued at $24 billion. The industry’s impact on U.S. GDP is upwards of $2.9 trillion.

Cambridge Major Laboratories, Inc. and AAIPharma Services Corp. have joined to form a world-class supplier of comprehensive pharmaceutical development and manufacturing services. With nearly 800 employees operating out of seven sites in the US and Europe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (solid dose and parenteral), packaging, and stability services.

Cambridge Major Laboratories, Inc. (CML) is a leading global chemistry outsourcing partner to the pharmaceutical and biotechnology industries. The Company produces pharmaceutical intermediates and Active Pharmaceutical Ingredients (API), from early preclinical development to commercial manufacture. Operating from FDA inspected facilities in the US and Europe, CML is organized along five key Centers of Excellence including; Process Chemistry, GMP Manufacturing, Solid State Chemistry, Analytical Services, and Quality/Regulatory Compliance. Visit us at www.c-mlabs.com.Specialties:API Developoment,API Manufacture,Drug Development,Active Pharmaceutical Ingredients,Solid State Chemistry,Analytical Chemistry,Process Development,preclinical,clinical trials,commercial,commercial API manufacture

BioForward is the member-driven state association that is the voice of Wisconsin’s bioscience industry and a state chapter of the national Biotechnology Industry Organization. We advocate actively on our members’ behalf for public policy that supports the industry, save our members money through our Select Savings group purchasing program, and provide a variety of opportunities for connections to funding, partners, customers, and employers and employees through our events and online resources. Our professional, service oriented staff also provide one-on-one support to members with specific requests. Our members include bioscience companies, universities, non-profits, service providers, and government agencies.

Successfully developed and promoted the company's proprietary licensed technology portfolio. Leading driver of the company's global business development team, focused on growing revenue in the biotech and emerging pharma sector.

Responsible for developing sales, marketing, and technical support functions from the ground up. The company was later acquired by Johnson Matthey.

Catalyst and separations research, as well as developed and promoted SMB continuous chromatography technology to the pharmaceutical and fine chemical sector.